Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
500087:BOM
Cipla Ltd
₹1,295.00
-0.83%
(-10.85) 1D
Apr 24, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500087...
Open
₹1,304.90
High
₹1,304.90
Low
₹1,254.75
Mkt. cap
1.05T
Avg. vol.
133.02K
Volume
125.66K
Dividend
1.00%
Quarterly dividend
₹3.25
Ex dividend date
Aug 2, 2024
P/E ratio
23.02
52-wk high
₹1,672.20
52-wk low
₹1,165.55
EPS
₹56.26
Shares outstanding
805.67M
No. of employees
30K
News stories
From sources across the web
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees30.3K
Founded1935
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websitecipla.com
Last report
Jan 23, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
10.94/ (15.55 est.)INR
-29.67%miss
Revenue / Estimate
69.63B/ (75.66B est.)INR
-7.97%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
67.20B
68.37B
74.47B
69.63B
Cost of goods sold
24.35B
21.71B
24.98B
26.32B
Cost of revenue
24.35B
21.71B
24.98B
26.32B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.07B
13.12B
13.15B
13.25B
Operating expense
29.47B
31.41B
33.52B
33.54B
Total operating expenses
53.83B
53.12B
58.50B
59.86B
Operating income
13.37B
15.25B
15.98B
9.77B
Other non operating income
-2.89B
2.59B
2.69B
2.06B
EBT including unusual items
14.93B
17.69B
18.54B
8.93B
EBT excluding unusual items
12.96B
17.69B
18.54B
11.69B
Income tax expense
2.79B
4.78B
5.00B
2.19B
Effective tax rate
18.70%
27.01%
27.00%
24.48%
Other operating expenses
2.40B
15.76B
17.40B
17.51B
Net income
12.22B
12.98B
13.51B
6.76B
Net profit margin
18.18%
18.98%
18.14%
9.71%
Earnings per share
15.12
16.06
16.72
10.94
Interest and investment income
2.68B
-
-
-
Interest expense
-
-140.50M
-131.80M
-140.30M
Net interest expenses
2.68B
-140.50M
-131.80M
-140.30M
Depreciation and amortization charges
2.01B
2.53B
2.97B
2.78B
EBITDA
15.60B
17.49B
18.73B
12.00B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer